Alta Sciences

JANUARY 31, 2025

About the author Ria Falvo, BSc, DABT Ria Falvo joined Altasciences in July 2022 as Director of Reporting (Safety Assessment), leading initiatives to streamline preclinical reporting processes, working closely with scientific and operations management to oversee report content, timelines, and the training of study directors in report writing.

Cell Biology 52

Cell Biology Pharmaceutical Companies Clinical Research Government 52

Drug Target Review

AUGUST 24, 2023

Shear forces induce ICAM-1 nanoclustering on endothelial cells that impact on T-cell migration. Current Opinion in Cell Biology. LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade. 2022 Jul 1;132(13). Biophysical Journal. 2021 Jul 6;120(13):2644-56.

Treatment 98

Treatment Therapies Clinical Development Cell Biology 98

Drug Target Review

SEPTEMBER 19, 2023

Recent Nature publication (2022) demonstrates the speed and accuracy at which patient derived organoids contributed to a large scale functional screen of bispecific antibodies on a heterogenous colorectal cancer that reached clinical trials within 5 years from the initial development. From 3D cell culture to organs-on-chips.

Animal Testing 98

Animal Testing Clinical Trials Pharmaceutical Companies FDA 98

Drug Target Review

MAY 21, 2024

I don’t think that it’s harder for women to enter careers in STEM, at least not in the scientific field—cell biology—that I have predominantly worked in. The acquisition of Cellesce by Molecular Devices in 2022 celebrated Vicky’s leadership.

Doctors 59

Doctors Science Research Cell Biology 59

DrugBank

JUNE 27, 2023

Genome.gov [link] (2022). Network expansion of genetic associations defines a pleiotropy map of human cell biology. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 51 , D977–D985 (2023).  The Cost of Sequencing a Human Genome.  Wright, S. Paulden, M. &

Disease 98

Disease Treatment Drugs Clinical Trials 98

The Pharma Data

OCTOBER 22, 2020

The launch of INTERLINK-1 represents an important financial milestone for Innate, as it triggers a $50 million milestone payment that fortifies our cash position through the end of 2022, ” said Mondher Mahjoubi, Chief Executive Officer of Innate Pharma. “

Clinical Trials 40

Clinical Trials Trials Cell Biology Production 40

New Drug Approvals

JANUARY 9, 2024

As such, it has been proposed that inhibiting CDK7 would provide a potent means of inhibiting cell cycle progression, which may be especially relevant given that there is compelling evidence from gene knockout studies in mice for lack of an absolute requirement for CDK2, CDK4 and CDK6 for the cell cycle at least in most cell types (M alumbres et al.,

Production 62

Production DNA RNA Regulations 62

Drug Target Review

JUNE 5, 2023

As such, our team remains on track to complete our 5×5 strategy – laid out in October 2022 – by harnessing our technology and resources to continue efficiently growing Zymeworks’ pipeline of in-house and partnered candidates. Author Bio: Paul Moore, PhD Dr Moore joined Zymeworks in July 2022 as Chief Scientific Officer.

Treatment 101

Treatment Pharmacokinetics Drugs Cell Biology 101

PerkinElmer

JANUARY 21, 2022

Accelerating Capabilities for Dementia Biomarker Discovery To achieve that goal, the Dementia Platform’s focus involves studying the disease from many points of view – from lifestyle, age, and cognitive function, to genetics, cell biology, and phenotypic screening. 2022 [cited 6 January 2022]. Mrc.ukri.org.

Cell Biology 52

Cell Biology Disease Treatment Science 52

The Pharma Data

MARCH 11, 2021

At Crop Science we’re targeting above-market growth from 2022. Second, the biorevolution is driving innovation in all of Bayer’s divisions – with major progress in cell biology, gene editing and data science. rate of 3 to 5 percent annually from 2022 through 2024, and thus faster than the market. “We

Science 52

Science Pharmaceuticals Licensing Licensing 52

The Pharma Data

MARCH 25, 2022

. “With the help of advanced laboratory techniques, we were able to identify a panel of nanobodies that very effectively neutralized several variants of SARS-CoV-2,” says Gerald McInerney, professor at the Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, and joint senior author of both studies.

Molecular Biology 52

Molecular Biology Laboratories Cell Biology Science 52

The Pharma Data

MARCH 15, 2022

. “The problem is that cells only make small amounts of p53 and then quickly break it down as it is a very large and disordered protein,” says the study’s last author Michael Landreh, researcher at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet. 2022.02.013. Source link: [link].

Cell Biology 52

Cell Biology DNA Research Vaccine 52

Broad Institute

JULY 28, 2023

He then moved to Boston where he received his postdoctoral training under the mentorship of Kerry Ressler at McLean Hospital, before he started his own lab in 2022. He is the recipient of several honors and fellowships, including a research scholarship from the German Research Foundation and NARSAD Young Investigator Awards in 2016 and 2022.

Medical Schools 52

Medical Schools Hospitals Regulations Research 52

BMG Labtech

MARCH 8, 2023

005 (inactive 31 December 2022). Alberts B, How Cells Obtain Energy from Food, Molecular Biology of the Cell (4th ed.). In Varki A, Cummings RD, Esko JD, Stanley P (eds.). Essentials of Glycobiology (3rd ed.). Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press. doi:10.1101/glycobiology.3e.005 PMID 28876856.

Molecular Biology 52

Molecular Biology Production Cell Based Assays Disease 52

Codon

APRIL 2, 2023

An open-source FACS automation system for high-throughput cell biology. Read GenScript, a company that does everything from DNA synthesis to cell line manufacturing, increased revenue by 27.7% from 2021 to 2022, up to $625 million. Might be useful! Wiener D.M. Press release. Press release. ’” Fierce Biotech.

DNA 52

DNA RNA Engineering Licensing 52

Codon

APRIL 16, 2023

Nature Cell Biology. Read *Open-endedness in synthetic biology: a route to continual innovation for biological design. Read In Q1 2023, there was an 87% increase in biopharma layoffs, with 56 companies cutting staff compared to 30 in the same period of 2022. Nature Biotechnology. coli DNA using a Retro-Cascorder.

Engineering 52

Engineering DNA RNA Science 52

Drug Target Review

JANUARY 16, 2025

She has a PhD in Microbiology and Cell Biology from the University of Illinois, followed by work in biochemistry as a post-doctoral fellow at UCSF. Cell , 185(19):35203532, 2022. Ajay N Jain Ajay is VP of Research for the Optibrium s BioPharmics Division. Drug Discovery Today , 18(13-14):659666, 2013.

Drug Development 52

Drug Development Small Molecule Drugs FDA Approval 52

Codon

AUGUST 10, 2023

Nature Reviews Molecular Cell Biology (2009). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nature Reviews Molecular Cell Biology (2014). Synthesis.cc (2022).

DNA 98

DNA Cell Biology Molecular Biology Engineering 98

Codon

AUGUST 10, 2023

Nature Reviews Molecular Cell Biology (2009). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nature Reviews Molecular Cell Biology (2014). Synthesis.cc (2022).

DNA 52

DNA Cell Biology Engineering Molecular Biology 52